oxazolidin-2-one has been researched along with Acute Coronary Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Golwala, H; Lozano, P; Smith, M | 1 |
| Einecke, D | 1 |
| Deanfield, J; Kastelein, J; Landmesser, U; Lüscher, TF; von Eckardstein, A | 1 |
3 other study(ies) available for oxazolidin-2-one and Acute Coronary Syndrome
| Article | Year |
|---|---|
Zolmitriptan induced acute coronary syndrome: a unique case.
Topics: Acute Coronary Syndrome; Chest Pain; Electrocardiography; Humans; Male; Middle Aged; Migraine Disorders; Myocardial Infarction; Nitroglycerin; Oxazolidinones; Serotonin 5-HT1 Receptor Agonists; Tryptamines; Vasodilator Agents | 2011 |
[Secondary coronary heart disease prevention. Will CEPT inhibitors be the next breakthrough?].
Topics: Acute Coronary Syndrome; Amides; Benzodiazepines; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Delayed-Action Preparations; Drug Therapy, Combination; Drugs, Investigational; Esters; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Niacin; Oxazolidinones; Randomized Controlled Trials as Topic; Sulfhydryl Compounds | 2011 |
Increasing high-density lipoprotein cholesterol by cholesteryl ester transfer protein-inhibition: a rocky road and lessons learned? The early demise of the dal-HEART programme.
Topics: Acute Coronary Syndrome; Amides; Anticholesteremic Agents; Atherosclerosis; Cardiovascular Diseases; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Early Termination of Clinical Trials; Esters; Humans; Oxazolidinones; Quinolines; Randomized Controlled Trials as Topic; Sulfhydryl Compounds | 2012 |